The proposed combination of Paramount Global (following its merger with Skydance) and Warner Bros. Discovery carries an enterprise value of approximately $110 billion. The U.S. Department of Justice approved the transaction in June 2026.

On July 13, 2026, a coalition of twelve states led by California filed suit to block the merger on antitrust grounds, independent of the federal approval already obtained.

The states allege that the combined entity would control approximately:

• ~27% of the U.S. general theatrical film distribution market
• ~30% of blockbuster film distribution
• ~27% of the core cable television channel market

The core claims are:

• Increased bargaining power against movie theaters and pay-television distributors
• Higher prices for consumers
• Reduced quantity and diversity of content

The states have announced they will seek a court order requiring the parties to delay closing pending resolution of the litigation — and, if refused, will seek a temporary restraining order or preliminary injunction.

The filing illustrates a critical structural feature of U.S. merger law: state attorneys general can challenge a merger in court independently of federal antitrust authorities, even after DOJ or FTC clearance has been obtained. Federal approval does not preempt state antitrust enforcement.

The litigation is expected to take months to resolve. This materially affects the transaction's economics:

• Paramount reportedly has an obligation to pay WBD shareholders approximately $650 million per quarter in ticking fees if the deal does not close by September 30
• Financing commitments, the long-stop date, ticking fee obligations, and each party's termination rights become critical pressure points

Practical conclusion: The state lawsuit — previously a known risk — has now been filed. The probability of material delay, renegotiation, or outright failure of the transaction has increased significantly.

TransDigm Group had agreed to acquire Stellant Systems from private equity firm Arlington Capital Partners for approximately $960 million in cash. Stellant manufactures high-power radio frequency and microwave electronic components for defense, space, and commercial aviation platforms. The company had projected approximately $300 million in revenue for 2025, with roughly half derived from aftermarket sales.

TransDigm withdrew its relevant regulatory filing on July 10, 2026. Following the withdrawal, Arlington Capital Partners terminated the purchase agreement. TransDigm cited three factors:

1. Uncertainty in the regulatory review process
2. The difficulty of completing the transaction within the contractual time limits
3. The opportunity cost of foregone alternative acquisitions

The termination demonstrates that even sub-$1 billion defense sector transactions can become entangled in extended and ultimately unsuccessful antitrust review when the target produces critical, specialized components that create supply concentration in a sensitive sector.

It also provides a concrete example of how merger agreement mechanics — regulatory efforts obligations, outside dates, termination rights, and financing costs — can become the decisive factor in the economic decision to proceed or withdraw, independent of the underlying strategic rationale.

Key drafting considerations highlighted by this outcome:

• Regulatory efforts standard (reasonable / best efforts / hell-or-high-water) and its practical limits in defense M&A
• Outside date and extension mechanics when regulatory review is prolonged
• Termination fee allocation between buyer and seller upon regulatory failure
• Opportunity cost provisions and their absence in standard merger agreements

This analysis is prepared by ULF New York for informational purposes only and does not constitute legal advice. For guidance on antitrust compliance, merger agreement structuring, or regulatory risk management in cross-border transactions, contact our New York office.